HLB Life Science Signs Share Pledge Agreement Accompanying Change of Largest Shareholder

HLB Life Science announced on the 17th that a stock pledge agreement involving a change in the largest shareholder has been signed.

The pledge provider is HLB, owning 20,695,725 shares, accounting for 17.44% of the stake. The creditor, Mirae Asset Securities, has set a total collateral amount of 150 billion KRW, with 20,695,725 shares pledged as collateral. The collateral period is from the 21st of this month to November 21st.